NuCana plc SEC filings NCNA
NuCana plc has 282 filings in SEC EDGAR's recent list, going back to Jun 26, 2017. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| F-6 POS | Filing | Jul 16, 2025 | — |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| F-3/A | Filing | Jun 18, 2025 | — |
| 424B4 | Prospectus | May 7, 2025 | — |
| F-1/A | Filing | May 2, 2025 | — |
| F-1/A | Filing | Apr 29, 2025 | — |
| F-6 | Filing | Apr 24, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Apr 24, 2025 | — |
| 424B5 | Prospectus supplement | Oct 1, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 15, 2024 | — |
| F-6 POS | Filing | Mar 27, 2024 | — |
| 424B5 | Prospectus supplement | Mar 27, 2024 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 19, 2021 | — |
| 424B5 | Prospectus supplement | Sep 17, 2020 | — |
| 424B5 | Prospectus supplement | Sep 16, 2020 | — |
| S-8 | Employee stock plan registration | Aug 19, 2020 | — |
| 424B5 | Prospectus supplement | Jan 23, 2019 | — |
| 424B5 | Prospectus supplement | Dec 21, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 1, 2018 | — |
| S-8 | Employee stock plan registration | Mar 7, 2018 | — |
| 424B4 | Prospectus | Sep 29, 2017 | — |
| F-6/A | Filing | Sep 22, 2017 | — |
| F-1/A | F-1/a - amendment no. 2 | Sep 21, 2017 | — |
| F-1/A | Filing | Sep 18, 2017 | — |
| F-6 | Filing | Sep 8, 2017 | — |
| F-1 | Registration statement (foreign issuer) | Sep 1, 2017 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NCNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Edinburgh, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1709626
- Former names
- NuCana BioMed Ltd (until Aug 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.